Transcriptomics in Atherosclerosis: Deciphering Molecular Signatures and Advancing Therapeutic Strategies integrates transcriptomic research and RNA-based therapeutics to understand and treat atherosclerosis. Emphasizing the power of genetic insights to revolutionize cardiovascular medicine, this book fills an essential gap by offering up-to-date insights into molecular mechanisms, diagnostic innovations, and therapeutic strategies, fostering a new era of personalized cardiovascular care. It addresses cutting-edge RNA sequencing methods, clinical translation, multi-omics integration, phenotyping, and treatment stratification, providing a holistic view of vascular pathology. Other important points include a focus on RNA-based biomarkers and therapeutics for early detection, monitoring, and targeted interventions in atherosclerosis.Readers will find advanced transcriptomic technologies, including single-cell and spatial transcriptomics, which unveil the complexities of atherosclerotic disease. The book promises to be a valuable resource for medical professionals seeking to deepen their knowledge in this burgeoning field. - Unravels the molecular intricacies of atherosclerosis using the latest transcriptomic technologies, offering new perspectives on disease mechanisms and potential therapeutic targets - Highlights the transformative potential of RNA molecules in advancing diagnostics and developing novel RNA-based treatments for personalized medicine in cardiovascular care - Provides actionable insights into translating transcriptomic findings into clinical applications, enhancing patient stratification and treatment strategies
